Temat: "Sustained virologic response" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Autorzy:: Lopes SS; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Pericot-Valverde I; Department of Psychology, College of Behavioral, Social, and Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Lum PJ; Department of Medicine, University of California, San Francisco, 1001 Potrero Ave, 94110, San Francisco, CA, USA.
Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, 7 Greenhouse Road, 02881, Kingston, RI, USA.
Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6546, 21205, Baltimore, MD, USA.
Tsui JI; Department of Medicine, University of Washington, 325 9th Ave, 98104, Seattle, WA, USA.
Feinberg J; Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, 930 Chestnut Ridge Road, 26505, Morgantown, WV, USA.; Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, 1 Medical Center Drive, 26506, Morgantown, WV, USA.
Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St, 02114, Boston, MA, USA.; Harvard Medical School, 02115, Boston, MA, USA.
Norton BL; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Page K; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Murray-Krezan C; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, 15213, Pittsburgh, PA, USA.
Anderson J; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Karasz A; UMass Chan Medical School, University of Massachusetts Medical School, 55 Lake Ave, North, 01605, Worcester, MA, USA.
Arnsten J; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Moschella P; Department of Emergency Medicine, Prisma Health, Greenville, SC, USA.; School of Health Research, Clemson University, Clemson, SC, USA.; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA.
Heo M; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA. .; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA. .; Department of Medicine, Prisma Health, 29605, Greenville, SC, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 251. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C*/complications
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China.
Autorzy:: Huang R; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, No.11 Xizhimen South Street, Beijing, 100044, China.
Shang J; Henan Provincial People's Hospital, No.7 Weiwu Street, Zhengzhou, 463599, China.
Chen H; First Hospital of Lanzhou University, No.1 Donggang west Street, Lanzhou, 730013, China.
Li J; First Affiliated Hospital with Nanjing Medical University, No.22 Hankou Street, Nanjing, 210033, China.
Xie Q; Medical College, Ruijin Hospital, Shanghai Jiaotong University, No. 573, Xujiahui Street, Shanghai, 200020, China.
Feng J; Department of Marketing, School of Business, Renmin University of China, No. 59 Zhongguancun Avenue, Beijing, 100871, China.
Wei L; Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, No.168, Litang Road, Changping District, Beijing, 102218, China.
Rao H; Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing International Cooperation Base for Science and Technology On NAFLD Diagnosis, No.11 Xizhimen South Street, Beijing, 100044, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 10; Vol. 24 (1), pp. 72. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Observational Study; Multicenter Study; Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Hepatitis C*
Adult ; Male ; Humans ; Middle Aged ; Female ; Prospective Studies ; Quality of Life ; Sustained Virologic Response ; China ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Autorzy:: Liégeois F; Institut de Recherche pour le Développemen, Inserm, Univ Montpellier, TransVIHMI, 911 avenue Agropolis, BP 64501, 34394, Montpellier, cedex 5, France.; CREMER, Yaoundé, Cameroon.; Present Address: IRD, CNRS, Univ Montpellier, MIVEGEC, Montpellier, France.
Boyer S; Inserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Eymard-Duvernay S; Institut de Recherche pour le Développemen, Inserm, Univ Montpellier, TransVIHMI, 911 avenue Agropolis, BP 64501, 34394, Montpellier, cedex 5, France.
Carrieri P; Inserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Kouanfack C; Central Hospital, Yaoundé, Cameroon.; Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Domyeum J; CREMER, Yaoundé, Cameroon.
Maradan G; Inserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Ducos J; Laboratory of Viral Hepatitis, Inserm, University Hospital, Montpellier, France.
Mpoudi-Ngolé E; CREMER, Yaoundé, Cameroon.
Spire B; Inserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Delaporte E; Institut de Recherche pour le Développemen, Inserm, Univ Montpellier, TransVIHMI, 911 avenue Agropolis, BP 64501, 34394, Montpellier, cedex 5, France.
Kuaban C; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Vidal L; Inserm, IRD, Univ Aix-Marseille, SESSTIM, Marseille, France.
Laurent C; Institut de Recherche pour le Développemen, Inserm, Univ Montpellier, TransVIHMI, 911 avenue Agropolis, BP 64501, 34394, Montpellier, cedex 5, France. .; Pokaż więcej
Corporate Authors:: EVOLCAM study group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Jan 15; Vol. 20 (1), pp. 49. Date of Electronic Publication: 2020 Jan 15.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Sustained Virologic Response*
Coinfection/*drug therapy
HIV Infections/*drug therapy
Hepatitis B/*drug therapy
Hepatitis B/*virology
Hepatitis B virus/*genetics
Adult ; Anti-Retroviral Agents/therapeutic use ; Cameroon ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Genotype ; Hepatitis B Surface Antigens/blood ; Humans ; Male ; Middle Aged ; Public Health ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis.
Autorzy:: Wang YW; Healthcare and Management Center, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Lee WP; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Institute of Biochemistry and Molecular Biology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Huang YH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Institute of Clinical Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Hou MC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Lan KH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei, 112, Taiwan, ROC. .; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC. .; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 Sep 21; Vol. 21 (1), pp. 984. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Genotype ; Hepacivirus ; Humans ; Lipoproteins, LDL ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Sustained Virologic Response ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
Autorzy:: Quaranta MG; Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
Ferrigno L; Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
Tata X; University of Tor Vergata, Nostra Signora del Buon Consiglio di Tirana, Tirana, Albania.
D'Angelo F; Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
Coppola C; Department of Hepatology, Gragnano Hospital, Naples, Italy.
Ciancio A; Gastroenterology Unit, University of Turin, Turin, Italy.
Bruno SR; Infectious Diseases, Ospedali Riuniti, Foggia, Italy.
Loi M; Liver Unit, University Hospital, Monserrato, Cagliari, Italy.
Giorgini A; Department of Health Sciences, San Paolo Hospital, University of Milan, Milan, Italy.
Margotti M; Department of Internal Medicine, University Hospital of Modena, Modena, Italy.
Cossiga V; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Brancaccio G; Department of Infectious Disease, University of Padua, Padua, Italy.
Dallio M; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
De Siena M; Department of Internal Medicine and Gastroenterology, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Cannizzaro M; Internal Medicine, Villa Sofia-Cervello Hospital, Palermo, Italy.
Cavalletto L; Department of Medicine, University Hospital of Padua, Padua, Italy.
Massari M; Infectious Diseases, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Mazzitelli M; Department of Infectious Disease, University Hospital Mater Domini, Catanzaro, Italy.
De Leo P; Department of Infectious Disease, San Paolo Hospital, Savona, Italy.
Laccabue D; Unit of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Baiocchi L; Department of Medical Sciences, University of Tor Vergata, Rome, Italy.
Kondili LA; Center for Global Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 May 04; Vol. 21 (1), pp. 413. Date of Electronic Publication: 2021 May 04.
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:: Antiviral Agents/*therapeutic use
Hepatitis C/*drug therapy
Liver Cirrhosis/*virology
Aged ; Coinfection/drug therapy ; Female ; HIV Infections/drug therapy ; Hepacivirus/genetics ; Hepatitis C/complications ; Hepatitis C/virology ; Humans ; Liver Cirrhosis/drug therapy ; Liver Function Tests ; Male ; Middle Aged ; Prospective Studies ; Sustained Virologic Response ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.
Autorzy:: Umemura M; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Suda G; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan. .; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. .
Tsukamoto S; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Ebata K; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Takahash S; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Sasaki T; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Nakajima S; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Hirata K; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Ozasa M; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Takano M; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Katagiri M; Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan.
Sakamoto N; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 Apr 27; Vol. 21 (1), pp. 389. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Aminoisobutyric Acids/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Antiviral Agents/*administration & dosage
Benzimidazoles/*administration & dosage
Cyclopropanes/*administration & dosage
Hepacivirus/*genetics
Hepatitis C/*complications
Hepatitis C/*drug therapy
Lactams, Macrocyclic/*administration & dosage
Leucine/*analogs & derivatives
Lymphoma, Large B-Cell, Diffuse/*complications
Lymphoma, Large B-Cell, Diffuse/*drug therapy
Proline/*analogs & derivatives
Quinoxalines/*administration & dosage
Sulfonamides/*administration & dosage
Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Genotype ; Humans ; Leucine/administration & dosage ; Male ; Middle Aged ; Prednisone/therapeutic use ; Proline/administration & dosage ; Pyrrolidines ; RNA, Viral/blood ; RNA, Viral/genetics ; Rituximab/therapeutic use ; Sustained Virologic Response ; Vincristine/therapeutic use ; Viral Load/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report.
Autorzy:: Aldunate F; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay.; Laboratorio de Evolución Experimental de Virus, Institut Pasteur de Montevideo, Mataojo 2020, ZIP: 11400, Montevideo, Uruguay.
Echeverría N; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay.; Laboratorio de Evolución Experimental de Virus, Institut Pasteur de Montevideo, Mataojo 2020, ZIP: 11400, Montevideo, Uruguay.
Chiodi D; Clínica de Gastroenterología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Av. Italia s/n, ZIP: 11600, Montevideo, Uruguay.
López P; Laboratorio de Patología Clínica, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Av. Italia s/n, ZIP: 11600, Montevideo, Uruguay.
Sánchez-Cicerón A; Clínica de Gastroenterología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Av. Italia s/n, ZIP: 11600, Montevideo, Uruguay.
Soñora M; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay.; Laboratorio de Simulaciones Biomoleculares, Institut Pasteur de Montevideo, Mataojo 2020, ZIP: 11400, Montevideo, Uruguay.
Cristina J; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay.
Moratorio G; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay.; Laboratorio de Evolución Experimental de Virus, Institut Pasteur de Montevideo, Mataojo 2020, ZIP: 11400, Montevideo, Uruguay.
Hernández N; Clínica de Gastroenterología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Av. Italia s/n, ZIP: 11600, Montevideo, Uruguay.
Moreno P; Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, ZIP: 11400, Montevideo, Uruguay. .; Laboratorio de Evolución Experimental de Virus, Institut Pasteur de Montevideo, Mataojo 2020, ZIP: 11400, Montevideo, Uruguay. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 Apr 26; Vol. 21 (1), pp. 387. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Drug Resistance, Viral/*genetics
Fluorenes/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Ribavirin/*therapeutic use
Sofosbuvir/*therapeutic use
Drug Therapy, Combination ; Genotype ; Hepatitis C, Chronic/virology ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Middle Aged ; RNA, Viral/blood ; RNA, Viral/genetics ; Recurrence ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
Autorzy:: Haghighat R; Department of Social Policy and Intervention, University of Oxford, 32 Wellington Square, Oxford, OX1 3DW, UK. .
Toska E; Centre for Social Science Research, University of Cape Town, Cape Town, South Africa.; Department of Sociology, University of Cape Town, Cape Town, South Africa.
Bungane N; Department of Nursing Science, Faculty of Health Sciences, University of Fort Hare, Alice, South Africa.
Cluver L; Department of Social Policy and Intervention, University of Oxford, 32 Wellington Square, Oxford, OX1 3DW, UK.; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 Jan 13; Vol. 21 (1), pp. 60. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*epidemiology
HIV-1/*genetics
Adolescent ; Child ; Continuity of Patient Care ; Female ; Follow-Up Studies ; HIV Infections/mortality ; HIV Infections/virology ; Humans ; Logistic Models ; Longitudinal Studies ; Male ; RNA, Viral/genetics ; Retrospective Studies ; South Africa/epidemiology ; Sustained Virologic Response ; Viral Load/drug effects ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections.
Autorzy:: Gan W; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China.
Li J; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China.
Zhang C; First Department of Liver Disease, Guangzhou Eighth People's Hospital, Guangzhou, 510000, Guangdong Province, China.
Chen X; Department of Infectious Disease, Guangdong General Hospital, Guangzhou, 510000, Guangdong Province, China.
Lin C; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China. .
Gao Z; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Dec 07; Vol. 20 (1), pp. 931. Date of Electronic Publication: 2020 Dec 07.
Typ publikacji:: Clinical Trial, Phase IV; Journal Article; Multicenter Study
MeSH Terms:: Adenine/*analogs & derivatives
Antiviral Agents/*adverse effects
Hepatitis B e Antigens/*blood
Hepatitis B virus/*genetics
Hepatitis B, Chronic/*drug therapy
Organophosphonates/*administration & dosage
Telbivudine/*adverse effects
Adenine/administration & dosage ; Adult ; Alanine Transaminase/blood ; Antiviral Agents/administration & dosage ; China/epidemiology ; Creatinine/blood ; DNA, Viral/analysis ; Drug Therapy, Combination ; Female ; Glomerular Filtration Rate ; Hepatitis B Surface Antigens/blood ; Hepatitis B Surface Antigens/immunology ; Hepatitis B e Antigens/immunology ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/epidemiology ; Hepatitis B, Chronic/virology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sustained Virologic Response ; Telbivudine/administration & dosage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial.
Autorzy:: Pericot-Valverde I; School of Health Research, Clemson University, Clemson, SC, USA.; Department of Medicine, Prisma Health, Greenville, SC, USA.
Heo M; Department of Public Health Sciences, College of Behavioral, Social, and Health Sciences, Clemson University, Clemson, SC, USA.
Akiyama MJ; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Norton BL; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Agyemang L; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Niu J; School of Mathematical and Statistical Sciences, College of Science, Clemson University, Clemson, SC, USA.
Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA. .; Department of Medicine, Prisma Health, Greenville, SC, USA. .; Department of Medicine, University of South Carolina School of Medicine, Greenville, SC, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Dec 04; Vol. 20 (1), pp. 928. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Analgesics, Opioid/*therapeutic use
Antiviral Agents/*therapeutic use
Cigarette Smoking/*epidemiology
Hepacivirus/*genetics
Hepatitis C/*drug therapy
Hepatitis C/*epidemiology
Substance Abuse, Intravenous/*epidemiology
Adult ; Aged ; Female ; Follow-Up Studies ; Hepatitis C/virology ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Prevalence ; Quality of Life ; RNA, Viral/genetics ; Risk Factors ; Sustained Virologic Response ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: A packaged intervention to improve viral load monitoring within a deeply rural health district of South Africa.
Autorzy:: Brijkumar J; University of KwaZulu Natal, Nelson R Mandela School of Medicine, Durban, South Africa.
Johnson BA; University of Rochester, Rochester, NY, USA.
Zhao Y; Emory University Rollins School of Public Health, Atlanta, GA, USA.
Edwards J; Emory University Rollins School of Public Health, Atlanta, GA, USA.
Moodley P; School of Laboratory Medicine and Medical Sciences, National Health Laboratory Service, University of KwaZulu-Natal, Durban, South Africa.
Pathan K; Emory University Rollins School of Public Health, Atlanta, GA, USA.
Pillay S; University of KwaZulu Natal, Nelson R Mandela School of Medicine, Durban, South Africa.
Castro KG; Emory University Rollins School of Public Health, Atlanta, GA, USA.
Sunpath H; University of KwaZulu Natal, Nelson R Mandela School of Medicine, Durban, South Africa.
Kuritzkes DR; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Moosa MYS; University of KwaZulu Natal, Nelson R Mandela School of Medicine, Durban, South Africa.
Marconi VC; Emory University Rollins School of Public Health, Atlanta, GA, USA. .; Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA. .; Emory Vaccine Center, Atlanta, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Nov 11; Vol. 20 (1), pp. 836. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji:: Journal Article
MeSH Terms:: Epidemiological Monitoring*
Rural Health*
Acquired Immunodeficiency Syndrome/*epidemiology
HIV-1/*genetics
Viral Load/*methods
Acquired Immunodeficiency Syndrome/drug therapy ; Acquired Immunodeficiency Syndrome/virology ; Adult ; Anti-Retroviral Agents/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prevalence ; Rural Population ; South Africa/epidemiology ; Sustained Virologic Response ; Viral Load/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
Autorzy:: Ramsay J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, Perth, Australia.
Marsh J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, Perth, Australia.
Pedrana A; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Andric N; Homeless Healthcare, West Leederville, Perth, Australia.
Norman R; School of Public Health, Curtin University, Bentley, Australia.
Cheng W; Department of Gastroenterology and Hepatology, Royal Perth Hospital, Perth, Australia.; UWA Medical School, University of Western Australia, Perth, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
Webb S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; St John of God Hospital, Subiaco, Perth, Australia.
Zeps N; Epworth HealthCare, Eastern Clinical School of Monash University, Melbourne, Australia.
Bellgard M; eResearch Office, Queensland University of Technology, Brisbane, Australia.
Graves T; Berry Consultants, Austin, TX, USA.
Hellard M; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Australia.; Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Snelling T; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, Perth, Australia. .; School of Public Health, Curtin University, Bentley, Australia. .; Menzies School of Health Research, Charles Darwin University, Darwin, Australia. .; Department of Infectious Diseases, Perth Children's Hospital, Perth, Australia. .; School of Public Health, University of Sydney, Camperdown, Sydney, New South Wales, 2006, Australia. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Oct 29; Vol. 20 (1), pp. 802. Date of Electronic Publication: 2020 Oct 29.
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:: Registries*
Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Australia/epidemiology ; Genotype ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/virology ; Humans ; Life Style ; Liver Cirrhosis/diagnosis ; Polymerase Chain Reaction ; Prospective Studies ; RNA, Viral/blood ; RNA, Viral/genetics ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
Autorzy:: Nakalega R; Makerere University-Johns Hopkins University (MU-JHU) Care LTD, Kampala, Uganda. .
Mukiza N; Baylor College of Medicine Children's Foundation, Kampala, Uganda.
Kiwanuka G; School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Makanga-Kakumba R; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.
Menge R; School of Social Sciences, College of Humanities and Social Sciences, Makerere University Kampala, Kampala, Uganda.
Kataike H; Makerere University-Johns Hopkins University (MU-JHU) Care LTD, Kampala, Uganda.
Maena J; Makerere University-Johns Hopkins University (MU-JHU) Care LTD, Kampala, Uganda.
Akello C; Makerere University-Johns Hopkins University (MU-JHU) Care LTD, Kampala, Uganda.
Atuhaire P; Makerere University-Johns Hopkins University (MU-JHU) Care LTD, Kampala, Uganda.
Matovu-Kiweewa F; Makerere University-Johns Hopkins University (MU-JHU) Care LTD, Kampala, Uganda.
Ndikuno-Kuteesa C; School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Debem H; Department of Public Health and Preventive Medicine, School of Medicine, University of Liverpool, Liverpool, UK.
Mujugira A; School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.; Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Oct 06; Vol. 20 (1), pp. 727. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:: Journal Article
MeSH Terms:: Rural Population*
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*epidemiology
HIV-1/*immunology
Viral Load/*drug effects
Adolescent ; Adult ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; HIV Infections/virology ; Humans ; Infant ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Risk Factors ; Serologic Tests ; Sustained Virologic Response ; Uganda/epidemiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy.
Autorzy:: Peng P; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.; Wuhan Pulmonary Hospital, Wuhan, 430030, Hubei, China.
Xu Y; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.
Fried MW; Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, NC, 27516, USA.
Di Bisceglie AM; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.; Saint Louis University Liver Center, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA.
Fan X; Division of Gastroenterology & Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA. .; Saint Louis University Liver Center, Saint Louis University School of Medicine, St. Louis, MO, 63104, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Aug 26; Vol. 20 (1), pp. 632. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji:: Journal Article
MeSH Terms:: Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C/*diagnosis
Hepatitis C/*drug therapy
High-Throughput Nucleotide Sequencing/*methods
Female ; Genome, Viral/genetics ; Hepatitis C/blood ; Humans ; Male ; RNA, Viral/blood ; Reverse Transcriptase Polymerase Chain Reaction ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.
Autorzy:: Skaathun B; Division of Infectious Diseases and Global Public Health, University of California San Diego, 9500 Gilman Drive MC 0507, La Jolla, CA, 92093, USA. .
Borquez A; Division of Infectious Diseases and Global Public Health, University of California San Diego, 9500 Gilman Drive MC 0507, La Jolla, CA, 92093, USA.
Rivero-Juarez A; Infectious Diseases Unit, Instituto Maimonides de Investigaciones Biomedicas de Cordoba (IMIBIC), Hospital Universitario Reina Sofia de Cordoba, Universidad de Cordoba, Cordoba, Spain.
Mehta SR; Division of Infectious Diseases and Global Public Health, University of California San Diego, 9500 Gilman Drive MC 0507, La Jolla, CA, 92093, USA.
Tellez F; Infectious Diseases Unit Hospital Universitario de Puerto Real, Instituto de Investigación e Innovación en Ciencias Biomédicas de la Provincia de Cádiz. Universidad de Cádiz, Cádiz, Spain.
Castaño-Carracedo M; Infectious Diseases Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Merino D; Infectious Diseases Unit. Hospitales Juan Ramón Jiménez e Infanta Elena de Huelva, Huelva, Spain.
Palacios R; Infectious Diseases Unit, Hospital Universitario Virgen de la Victoria. Complejo Hospitalario Provincial de Málaga, Málaga, Spain.
Macías J; Unidad de Enfermedades Infecciosas, Hospital Universitario de Valme. Instituto de Biomedicina de Sevilla (iBiS), Sevilla, Spain.
Rivero A; Infectious Diseases Unit, Instituto Maimonides de Investigaciones Biomedicas de Cordoba (IMIBIC), Hospital Universitario Reina Sofia de Cordoba, Universidad de Cordoba, Cordoba, Spain.
Martin NK; Division of Infectious Diseases and Global Public Health, University of California San Diego, 9500 Gilman Drive MC 0507, La Jolla, CA, 92093, USA.; Population Health Sciences, University of Bristol, Bristol, UK.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Aug 08; Vol. 20 (1), pp. 588. Date of Electronic Publication: 2020 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: Models, Theoretical*
HIV Infections/*pathology
Hepatitis C/*diagnosis
Antiviral Agents/therapeutic use ; Cohort Studies ; Coinfection/epidemiology ; Coinfection/pathology ; Hepatitis C/drug therapy ; Hepatitis C/epidemiology ; Homosexuality, Male ; Humans ; Male ; Prevalence ; Prospective Studies ; Spain/epidemiology ; Substance-Related Disorders/pathology ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients.
Autorzy:: Ollivier-Hourmand I; Department of Gastroenterology, University Hospital, Avenue de la côte de Nacre, 14000, Caen, France.
Lebedel L; Department of Gastroenterology, University Hospital, Avenue de la côte de Nacre, 14000, Caen, France. .
Lecouf A; Department of Nephrology, University Hospital, Caen, France.
Allaire M; Department of Gastroenterology, University Hospital, Avenue de la côte de Nacre, 14000, Caen, France.; Inserm U1149, Center for Research on Inflammation, Faculté de Médecine Xavier Bichat, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Nguyen TTN; Department of Gastroenterology, University Hospital, Avenue de la côte de Nacre, 14000, Caen, France.
Lier C; Department of Virology, University Hospital, Caen, France.
Dao T; Department of Gastroenterology, University Hospital, Avenue de la côte de Nacre, 14000, Caen, France.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Jul 16; Vol. 20 (1), pp. 522. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Kidney Transplantation*
Transplant Recipients*
Drug Resistance, Viral/*drug effects
Hepatitis E/*drug therapy
Hepatitis, Chronic/*drug therapy
Interferon-alpha/*therapeutic use
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Hepatitis E/virology ; Hepatitis E virus/drug effects ; Hepatitis E virus/physiology ; Hepatitis, Chronic/virology ; Humans ; Male ; Middle Aged ; Recombinant Proteins/therapeutic use ; Remission Induction ; Sustained Virologic Response ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders.
Autorzy:: de Gennaro N; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Piazza Giulio Cesare n. 11, 70124, Bari, Italy. .
Diella L; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Piazza Giulio Cesare n. 11, 70124, Bari, Italy.
Monno L; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Piazza Giulio Cesare n. 11, 70124, Bari, Italy.
Angarano G; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Piazza Giulio Cesare n. 11, 70124, Bari, Italy.
Milella M; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Piazza Giulio Cesare n. 11, 70124, Bari, Italy.
Saracino A; Clinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Piazza Giulio Cesare n. 11, 70124, Bari, Italy.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Mar 06; Vol. 20 (1), pp. 196. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Antiviral Agents/*therapeutic use
Coinfection/*drug therapy
HIV Infections/*drug therapy
Hepatitis C, Chronic/*drug therapy
Mental Disorders/*drug therapy
Aged ; Antiviral Agents/adverse effects ; Central Nervous System Depressants/adverse effects ; Central Nervous System Depressants/therapeutic use ; Coinfection/epidemiology ; Comorbidity ; Drug Interactions ; Drug Therapy, Combination ; Female ; HIV Infections/epidemiology ; Hepatitis C, Chronic/epidemiology ; Humans ; Male ; Mental Disorders/epidemiology ; Middle Aged ; Retrospective Studies ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
Autorzy:: Carvalho-Louro DM; Gastroenterology Unit, Instituto Hospital de Base, Brasilia, Federal District, 70322-000, Brazil. .
Soares EB; Gilead Sciences Farmacêutica do Brasil Ltd. and Liver Center at UFMG, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 04711-130, Brazil.
Trevizoli JE; Gastroenterology Unit, Instituto Hospital de Base, Brasilia, Federal District, 70322-000, Brazil.
Marra TMG; Postgraduate Program in Health Sciences and Technologies, University of Brasilia, Brasilia, Federal District, 70919-970, Brazil.
da Cunha ALR; Sabin Laboratory Ltd., Brasilia, Federal District, 70632-300, Brazil.
Rodrigues MP; Pneumology Unit, Faculty of Medicine, University of Brasilia, Brasilia, Federal District, 70673-432, Brazil.
Carvalho-Furtado ACL; Endocrinology Unit, Instituto Hospital de Base, Brasilia, Federal District, 70322-000, Brazil.
Dos Santos BTA; Subsecretaria de Atencao Integral a Saude, Secretaria do Estado de Saude do Distrito Federal, Brasilia, Federal District, 70770-200, Brazil.
de Assis da Rocha Neves F; Molecular Pharmacology Laboratory, Faculty of Health Sciences, University of Brasilia, Brasilia, Federal District, 70919-970, Brazil.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Feb 10; Vol. 20 (1), pp. 114. Date of Electronic Publication: 2020 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: Mass Screening*/statistics & numerical data
Hepacivirus/*isolation & purification
Hepatitis C/*diagnosis
Hepatitis C/*epidemiology
Adult ; Aged ; Antiviral Agents/therapeutic use ; Brazil/epidemiology ; Cross-Sectional Studies ; Female ; Genotype ; Hepacivirus/drug effects ; Hepacivirus/genetics ; Hepacivirus/immunology ; Hepatitis C/drug therapy ; Hepatitis C/virology ; Humans ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/pathology ; Male ; Middle Aged ; Prevalence ; Serologic Tests ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Autorzy:: Tsertsvadze T; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia. .; Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, Tbilisi, Georgia. .
Gamkrelidze A; National Center for Disease control and public health, 99, Kakheti highway, 0198, Tbilisi, Georgia.
Nasrullah M; Emerging Infections Program, Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA.
Sharvadze L; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.; Ivane Javakhishvili Tbilisi State University, Faculty of Medicine, Tbilisi, Georgia.; Hepatology Clinic HEPA, Tbilisi, Georgia.
Morgan J; Emerging Infections Program, Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA.
Shadaker S; Emerging Infections Program, Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA.
Gvinjilia L; CDC Foundation, Georgia Hepatitis C Elimination Program, Tbilisi, Georgia.
Butsashvili M; Clinic NeoLab, Tbilisi, Georgia.
Metreveli D; Medical Center Mrcheveli, Tbilisi, Georgia.
Kerashvili V; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Ezugbaia M; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Chkhartishvili N; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Abutidze A; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Kvaratskhelia V; Ministry of Labor, Health and Social Affairs of Georgia, Tbilisi, Georgia.
Averhoff F; Emerging Infections Program, Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis National Center for HIV, Hepatitis, STD&TB Prevention, Atlanta, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Jan 10; Vol. 20 (1), pp. 30. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji:: Journal Article
MeSH Terms:: National Health Programs*
Antiviral Agents/*therapeutic use
Hepatitis C, Chronic/*drug therapy
Hepatitis C, Chronic/*epidemiology
Interferons/*therapeutic use
Ribavirin/*therapeutic use
Sofosbuvir/*therapeutic use
Adolescent ; Adult ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Genotype ; Georgia (Republic)/epidemiology ; Hepacivirus/genetics ; Hepatitis C, Chronic/virology ; Humans ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/virology ; Lost to Follow-Up ; Male ; Middle Aged ; RNA, Viral/genetics ; Sustained Virologic Response ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
Autorzy:: Fadnes LT; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway. .; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. .
Aas CF; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Vold JH; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Ohldieck C; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.
Leiva RA; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Chalabianloo F; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Skurtveit S; Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway.; Department of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
Lygren OJ; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; ProLAR Nett, Oslo, Norway.
Dalgård O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Vickerman P; University of Bristol, Bristol, UK.
Midgard H; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
Løberg EM; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Psychology Medicine, University of Bergen, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Johansson KA; Bergen Addiction Research Group, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Pokaż więcej
Corporate Authors:: INTRO-HCV Study Group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2019 Nov 08; Vol. 19 (1), pp. 943. Date of Electronic Publication: 2019 Nov 08.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Opiate Substitution Treatment*
Antiviral Agents/*therapeutic use
Delivery of Health Care, Integrated/*methods
Hepacivirus/*genetics
Hepatitis C/*drug therapy
Substance Abuse, Intravenous/*drug therapy
Aftercare ; Cost-Benefit Analysis ; Counseling ; Female ; Hepatitis C/etiology ; Humans ; Male ; Norway ; Polymerase Chain Reaction ; Quality of Life ; Recurrence ; Substance Abuse, Intravenous/complications ; Sustained Virologic Response ; Treatment Adherence and Compliance

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Sustained virologic response"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język